Dr. Hubert Heinrichs
Studied medicine in Tübingen, doctorate in medicine, MBA and state examination in biology. From 1990 to 2006 worldwide project manager and director of clinical research at Aventis Behring in Marburg. Responsible for the liscensing of 5 medicines in Europe and the USA. From 2007 to 2013 managing director, CEO and CMO of Antisense Pharma GmbH at the BioPark, where he has sealed several rounds of finance successfully. From 2013 to 2014 advisor and advisory council member, 2015 managing director of Curadis GmbH at the BioPark. Independent consultant since 2016.